Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Integra LifeSciences Corp (NasdaqNM:IART)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials | Reports
Recent Events
Aug 27Price hit new 52-week high ($32.15)
Location
105 Morgan Lane
Plainsboro, NJ 08536
Phone: (609) 275-0500
Fax: (609) 799-3297
Employees (last reported count): 515
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Investor Relations
 ·Employment
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 67%
·Over the last 6 months:
 · 12 insider sells; 336.0K shares
  (1.9% of insider shares)
·Institutional: 28% (84% of float)
(81 institutions)
·Net Inst. Buying: 3.61M shares (+33.85%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Integra LifeSciences Holdings Corporation develops, manufactures and markets medical devices, implants and biomaterials. The Company's operations consist of Integra NeuroSciences, which is a provider of implants, devices and monitors used in neurosurgery, neurotrauma and related critical care, and Integra LifeSciences, which develops and manufactures a variety of medical products and devices, including products based on the Company's proprietary tissue regeneration technology that are used to treat soft tissue and orthopedic conditions. The Company manufactures and markets a multi-line offering of neurosurgical devices used for brain and spine injuries. The Integra LifeSciences Division develops and manufactures tissue regeneration products and surgical products that are primarily sold outside of neurosurgery and neurotrauma. Many of the products of Integra LifeSciences are built on the Company's expertise in resorbable collagen products.
More from Market Guide: Expanded Business Description

Financial Summary
Integra LifeSciences develops, manufactures and markets medical devices, implants and biomaterials. These products are primarily used in the diagnosis and treatment of acute neurosurgical, soft-tissue and orthopedic conditions. For the six months ended 6/01, revenues increased 41% to $44.6 million. Net income before accounting change applicable to Com. totalled $4 million vs. a loss of $5.8 million. Results reflect acquisitions, and decreased administrative expenses.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY1999 Pay

Richard Caruso, Ph.D., 56
Chairman
--  
Stuart Essig, 38
Pres, CEO
$309K
George McKinney, III, Ph.D., 56
Exec. VP, COO, Director
241K
John Henneman, III, 38
Sr. VP, CAO
163K
Donald Nociolo
Sr. VP, Operations
--  
Dollar amounts are as of 31-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:IARTAs of 31-Aug-2001
Price and Volume
52-Week Low
on 4-Oct-2000
$9.688
Recent Price$27.01 
52-Week High
on 27-Aug-2001
$32.15 
Beta0.64 
Daily Volume (3-month avg)407.8K
Daily Volume (10-day avg)378.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change+84.7%
52-Week Change
relative to S&P500
+147.8%
Share-Related Items
Market Capitalization$691.2M
Shares Outstanding25.6M
Float8.40M
Dividends & Splits
Annual Dividendnone 
Last Split: 1 for 2 on 26-May-1998
Per-Share Data
Book Value (mrq)$3.02 
Earnings (ttm)-$0.43 
Earnings (mrq)$0.10 
Sales (ttm)$4.00 
Cash (mrq)$0.56 
Valuation Ratios
Price/Book (mrq)8.95 
Price/EarningsN/A 
Price/Sales (ttm)6.75 
Income Statements
Sales (ttm)$84.6M
EBITDA (ttm)-$1.33M
Income available to common (ttm)-$6.83M
Profitability
Profit Margin (ttm)-6.2%
Operating Margin (ttm)-4.8%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-6.08%
Return on Equity (ttm)-12.75%
Financial Strength
Current Ratio (mrq)2.28 
Debt/Equity (mrq)0.15 
Total Cash (mrq)$11.7M
Short Interest
As of 8-Aug-2001
Shares Short355.0K
Percent of Float4.2%
Shares Short
(Prior Month)
175.0K
Short Ratio0.84 
Daily Volume423.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.